 |
|||||||||||||||
|
|
|||||||||||||||
|
 |
|||
| Spring Meeting Trial Reports: 2011 / 2010 / 2009 | |||
| ID | Study Title | Status | |
| IND.160 | A Phase II Study of CCI-779 in Patients with Metastatic and/or Locally Advanced Recurrent Endometrial Cancer MORE... | Closed | |
| IND.184 | A Phase II Study of Sunitinib, an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Patients with Unresectable, Locally Advanced or Metastatic Cervical Carcinoma MORE... | Permanently Closed | |
| IND.185 | A Phase II Study of Sunitinib (SU11248; NSC 736511) in Patients with Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma MORE... | Closed | |
| IND.192 | A Phase II Study of Deforolimus in Patients with Metastatic and/or Locally Advanced Recurrent Endometrial Cancer MORE... | Open | |
| IND.199 | A Phase II Study of Temsirolimus (NSC 683864), an mTOR Inhibitor, in Patients with Recurrent, Unresectable, Locally Advanced or Metastatic Carcimona of the Cervix MORE... | Closed | |
|
CX.4 GOG 0191 |
Phase III Trial to Evaluate the Efficacy of Maintaining Hemoglobin Levels Above 120 g/L with Erythropoietin versus Above 100 g/L without Erythropoietin in Anemic Patients Receiving Concurrent Radiation and Cisplatin for Cervical Cancer MORE... | Closed | |
|
CXC.1 GOG 0219 |
A Phase III, Randomized Trial of Weekly Cisplatin and Radiation versus Cisplatin and Tirapazamine and Radiation in Stage 1B2, IIA, IIB, IIIB and IVA Cervical Carcinoma Limited to the Pelvis MORE... | Closed | |
| EN.5 | A Phase III Randomized Trial Comparing TAH BSO versus TAH BSO plus Adjuvant Pelvic Irradiation in Intermediate Risk, Carcinoma of the Endometrium MORE... | Permanently Closed | |
|
EN.7 DCGOG PORTEC-3 |
Randomized Phase III Trial Comparing Concurrent Chemoradiation and Adjuvant Chemotherapy with Pelvic Radiation Alone in High Risk and Advanced Stage Endometrial Carcinoma MORE... | Open | |
|
GT.1 GOG 0174 |
A Randomized Phase III Trial of Weekly Parenteral Methotrexate versus "Pulsed" Dactinomycin for Primary Management of Low Risk Gestational Trophoblastic Neoplasia MORE... | Permanently Closed | |
|
OV.13 EORTC 55971 |
An International Multi-Centre Randomized Phase III Study Comparing Upfront Debulking Surgery versus Neo-Adjuvant Chemotherapy in Patients with Stage IIIC or IV Epithelial Ovarian Carcinoma MORE... | Closed | |
|
OV.15 AGO OVAR 2.5 |
International Randomized Phase III Study Comparing Gemcitabine plus Carboplatin versus Carboplatin Monotherapy in Patients with Advanced Epithelial Ovarian Carcinoma Who Failed First-Line Platinum-Based Therapy MORE... | Permanently Closed | |
| OV.16 | A Phase III Study of Cisplatin plus Topotecan Followed by Paciltaxel plus Carboplatin versus Paclitaxel Plus Carboplatin as First Line Chemotherapy in Women with Newly Diagnosed Advanced Epithelial Ovarian Cancer MORE... | Closed | |
|
OV.17 GINECO CALYPSO |
A Multi-National, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (Caelyx) and Carboplatin vs Paclitaxel and Carboplatin in Patients with Epithelial Ovarian Cancer in Late Relapse (> 6 months): GCIG Calypso Study MORE... | Closed | |
|
OV.18 MRC ICON 6 |
A Randomized Trial of Concurrent Cediranib [AZD2171] (with Platinum-Based Chemotherapy) and Maintenance Cediranib in Women with Platinum-Sensitive Relapsed Ovarian Cancer MORE... | Closed | |
|
OV.19 MRC ICON 7 |
A Randomized, Two-Arm, Multi-Centre Gynecologic Cancer Intergroup Trial of Adding Bevacizumab to Standard Chemotherapy (Carboplatin And Paclitaxel) in Patients with Epithelial Ovarian Cancer MORE... | Closed | |
| OV.21 | Phase II/III Trial of Intraperitoneal (IP) Plus Intravenous (IV) Chemotherapy Versus IV Carboplatin Plus Paclitaxel in Patients With Epithelial Ovarian Cancer Optimally Debulked at Surgery Following Neoadjuvant Intravenous Chemotherapy MORE... | Open | |
| If you have any questions, comments or suggestions, please contact our |